Matched molecular pair analysis in drug discovery
- PMID: 23557664
- DOI: 10.1016/j.drudis.2013.03.003
Matched molecular pair analysis in drug discovery
Abstract
Multiple parameter optimisation in drug discovery is difficult, but Matched Molecular Pair Analysis (MMPA) can help. Computer algorithms can process data in an unbiased way to yield design rules and suggest better molecules, cutting the number of design cycles. The approach often makes more suggestions than can be processed manually and methods to deal with this are proposed. However, there is a paucity of contextually specific design rules, which would truly make the technique powerful. By combining extracted information from multiple sources there is an opportunity to solve this problem and advance medicinal chemistry in a matter of months rather than years.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Breaking free from chemical spreadsheets.Drug Discov Today. 2015 Sep;20(9):1093-103. doi: 10.1016/j.drudis.2015.03.008. Epub 2015 Jun 4. Drug Discov Today. 2015. PMID: 26050579 Review.
-
QSAR-assisted-MMPA to expand chemical transformation space for lead optimization.Brief Bioinform. 2021 Sep 2;22(5):bbaa374. doi: 10.1093/bib/bbaa374. Brief Bioinform. 2021. PMID: 33418563
-
Matched Molecular Pair Analysis in Drug Discovery: Methods and Recent Applications.J Med Chem. 2023 Apr 13;66(7):4361-4377. doi: 10.1021/acs.jmedchem.2c01787. Epub 2023 Apr 4. J Med Chem. 2023. PMID: 37014039 Review.
-
Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.J Chem Inf Model. 2012 Jan 23;52(1):210-24. doi: 10.1021/ci2004779. Epub 2011 Dec 15. J Chem Inf Model. 2012. PMID: 22133077
-
Medicinal chemistry inspired fragment-based drug discovery.Methods Enzymol. 2011;493:421-45. doi: 10.1016/B978-0-12-381274-2.00016-9. Methods Enzymol. 2011. PMID: 21371600
Cited by
-
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP-Deleted Cancers.J Med Chem. 2024 Apr 25;67(8):6064-6080. doi: 10.1021/acs.jmedchem.4c00133. Epub 2024 Apr 10. J Med Chem. 2024. PMID: 38595098 Free PMC article.
-
Improved QSAR models for PARP-1 inhibition using data balancing, interpretable machine learning, and matched molecular pair analysis.Mol Divers. 2024 Feb 20. doi: 10.1007/s11030-024-10809-9. Online ahead of print. Mol Divers. 2024. PMID: 38374474
-
Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839.J Med Chem. 2024 Jan 25;67(2):1225-1242. doi: 10.1021/acs.jmedchem.3c01714. Epub 2024 Jan 16. J Med Chem. 2024. PMID: 38228402 Free PMC article.
-
DeepDelta: predicting ADMET improvements of molecular derivatives with deep learning.J Cheminform. 2023 Oct 27;15(1):101. doi: 10.1186/s13321-023-00769-x. J Cheminform. 2023. PMID: 37885017 Free PMC article.
-
Fast prediction of antibiotic permeability through membrane channels using Brownian dynamics.Biophys J. 2023 Jul 25;122(14):2996-3007. doi: 10.1016/j.bpj.2023.03.035. Epub 2023 Mar 28. Biophys J. 2023. PMID: 36992560 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources